Proteomic Analysis Resolves Distinct Molecular Signatures in Alzheimer’s Disease Brain Across Diverse Racial Groups.
Seifar F, Fox EJ, Shantaraman A, Liu Y, Modeste ES, Duong DM, Yin L, Gearing M, Lah JJ, Reddy JS, Allen M, Quicksall Z, Heath LM, Scanlan J, Wang E, Wang M, Linden AV, Poehlman WL, Chen X, Baheti S, Ho CCG, Nguyen T, Yepez‐Sisalema G, Mitchell AO, Oatman SR, Wang X, Carrasquillo MM, Runnels A, Beach TG, Golde T, Barnes LL, Haroutunian V, Zhang B, Jager PLD, Bennett DA, Greenwood A, Ertekin‐Taner N, Levey AI, Wingo AP, Wingo TS, Seyfried NT; Accelerating Medicine Partnership for Alzheimer’s (AMP‐AD) Diversity Initiative Disease.
Seifar F, et al. Among authors: mitchell ao.
Alzheimers Dement. 2025 Jan 9;20(Suppl 2):e092542. doi: 10.1002/alz.092542. eCollection 2024 Dec.
Alzheimers Dement. 2025.
PMID: 39785502
Free PMC article.